nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—Superinfection—Fluorouracil—colon cancer	0.0708	0.0708	CcSEcCtD
Cefixime—Superinfection—Capecitabine—colon cancer	0.0495	0.0495	CcSEcCtD
Cefixime—Pruritus genital—Capecitabine—colon cancer	0.0269	0.0269	CcSEcCtD
Cefixime—Blister—Fluorouracil—colon cancer	0.0223	0.0223	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Irinotecan—colon cancer	0.0185	0.0185	CcSEcCtD
Cefixime—Blood bilirubin increased—Irinotecan—colon cancer	0.0177	0.0177	CcSEcCtD
Cefixime—Colitis—Irinotecan—colon cancer	0.0161	0.0161	CcSEcCtD
Cefixime—Blister—Capecitabine—colon cancer	0.0156	0.0156	CcSEcCtD
Cefixime—Renal failure acute—Irinotecan—colon cancer	0.0132	0.0132	CcSEcCtD
Cefixime—Renal impairment—Irinotecan—colon cancer	0.0128	0.0128	CcSEcCtD
Cefixime—Anaphylactoid reaction—Irinotecan—colon cancer	0.0126	0.0126	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Capecitabine—colon cancer	0.0123	0.0123	CcSEcCtD
Cefixime—Dermatitis bullous—Fluorouracil—colon cancer	0.0122	0.0122	CcSEcCtD
Cefixime—Blood bilirubin increased—Capecitabine—colon cancer	0.0119	0.0119	CcSEcCtD
Cefixime—Colitis—Capecitabine—colon cancer	0.0108	0.0108	CcSEcCtD
Cefixime—Candida infection—Capecitabine—colon cancer	0.0107	0.0107	CcSEcCtD
Cefixime—Pancytopenia—Vincristine—colon cancer	0.0103	0.0103	CcSEcCtD
Cefixime—Neutropenia—Vincristine—colon cancer	0.0101	0.0101	CcSEcCtD
Cefixime—Eosinophilia—Fluorouracil—colon cancer	0.00998	0.00998	CcSEcCtD
Cefixime—Neutropenia—Irinotecan—colon cancer	0.00984	0.00984	CcSEcCtD
Cefixime—Pancytopenia—Fluorouracil—colon cancer	0.00958	0.00958	CcSEcCtD
Cefixime—Hepatic function abnormal—Capecitabine—colon cancer	0.00933	0.00933	CcSEcCtD
Cefixime—Renal failure—Irinotecan—colon cancer	0.00923	0.00923	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Methotrexate—colon cancer	0.00919	0.00919	CcSEcCtD
Cefixime—Jaundice—Irinotecan—colon cancer	0.00915	0.00915	CcSEcCtD
Cefixime—Haemolytic anaemia—Capecitabine—colon cancer	0.00903	0.00903	CcSEcCtD
Cefixime—Renal failure acute—Capecitabine—colon cancer	0.00883	0.00883	CcSEcCtD
Cefixime—Urinary tract infection—Fluorouracil—colon cancer	0.00874	0.00874	CcSEcCtD
Cefixime—Renal impairment—Capecitabine—colon cancer	0.00857	0.00857	CcSEcCtD
Cefixime—Dermatitis bullous—Capecitabine—colon cancer	0.00853	0.00853	CcSEcCtD
Cefixime—Haemoglobin—Irinotecan—colon cancer	0.00847	0.00847	CcSEcCtD
Cefixime—Haemorrhage—Irinotecan—colon cancer	0.00843	0.00843	CcSEcCtD
Cefixime—Agranulocytosis—Fluorouracil—colon cancer	0.00839	0.00839	CcSEcCtD
Cefixime—Vaginal inflammation—Methotrexate—colon cancer	0.00836	0.00836	CcSEcCtD
Cefixime—Haemoglobin—Fluorouracil—colon cancer	0.00811	0.00811	CcSEcCtD
Cefixime—Haemorrhage—Fluorouracil—colon cancer	0.00807	0.00807	CcSEcCtD
Cefixime—Vaginal infection—Methotrexate—colon cancer	0.00789	0.00789	CcSEcCtD
Cefixime—Face oedema—Capecitabine—colon cancer	0.00787	0.00787	CcSEcCtD
Cefixime—Aplastic anaemia—Methotrexate—colon cancer	0.00785	0.00785	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00734	0.00734	CcSEcCtD
Cefixime—Flatulence—Irinotecan—colon cancer	0.00723	0.00723	CcSEcCtD
Cefixime—Leukopenia—Vincristine—colon cancer	0.00674	0.00674	CcSEcCtD
Cefixime—Pancytopenia—Capecitabine—colon cancer	0.00669	0.00669	CcSEcCtD
Cefixime—Neutropenia—Capecitabine—colon cancer	0.00659	0.00659	CcSEcCtD
Cefixime—Renal failure acute—Methotrexate—colon cancer	0.00657	0.00657	CcSEcCtD
Cefixime—Leukopenia—Irinotecan—colon cancer	0.00657	0.00657	CcSEcCtD
Cefixime—Convulsion—Vincristine—colon cancer	0.00653	0.00653	CcSEcCtD
Cefixime—Leukopenia—Fluorouracil—colon cancer	0.00629	0.00629	CcSEcCtD
Cefixime—Anaphylactoid reaction—Methotrexate—colon cancer	0.00627	0.00627	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00623	0.00623	CcSEcCtD
Cefixime—Renal failure—Capecitabine—colon cancer	0.00618	0.00618	CcSEcCtD
Cefixime—Anaphylactic shock—Vincristine—colon cancer	0.00615	0.00615	CcSEcCtD
Cefixime—Jaundice—Capecitabine—colon cancer	0.00612	0.00612	CcSEcCtD
Cefixime—Urinary tract infection—Capecitabine—colon cancer	0.00611	0.00611	CcSEcCtD
Cefixime—Convulsion—Fluorouracil—colon cancer	0.00609	0.00609	CcSEcCtD
Cefixime—Thrombocytopenia—Vincristine—colon cancer	0.00602	0.00602	CcSEcCtD
Cefixime—Anaphylactic shock—Irinotecan—colon cancer	0.00599	0.00599	CcSEcCtD
Cefixime—Shock—Irinotecan—colon cancer	0.00589	0.00589	CcSEcCtD
Cefixime—Agranulocytosis—Capecitabine—colon cancer	0.00586	0.00586	CcSEcCtD
Cefixime—Thrombocytopenia—Irinotecan—colon cancer	0.00586	0.00586	CcSEcCtD
Cefixime—Anaphylactic shock—Fluorouracil—colon cancer	0.00573	0.00573	CcSEcCtD
Cefixime—Haemoglobin—Capecitabine—colon cancer	0.00567	0.00567	CcSEcCtD
Cefixime—Haemorrhage—Capecitabine—colon cancer	0.00564	0.00564	CcSEcCtD
Cefixime—Hepatitis—Capecitabine—colon cancer	0.00564	0.00564	CcSEcCtD
Cefixime—Thrombocytopenia—Fluorouracil—colon cancer	0.00561	0.00561	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00546	0.00546	CcSEcCtD
Cefixime—Erythema multiforme—Capecitabine—colon cancer	0.00533	0.00533	CcSEcCtD
Cefixime—Dyspepsia—Irinotecan—colon cancer	0.00527	0.00527	CcSEcCtD
Cefixime—Eosinophilia—Methotrexate—colon cancer	0.00519	0.00519	CcSEcCtD
Cefixime—Dyspepsia—Fluorouracil—colon cancer	0.00505	0.00505	CcSEcCtD
Cefixime—Gastrointestinal pain—Vincristine—colon cancer	0.00503	0.00503	CcSEcCtD
Cefixime—Pancytopenia—Methotrexate—colon cancer	0.00498	0.00498	CcSEcCtD
Cefixime—Neutropenia—Methotrexate—colon cancer	0.0049	0.0049	CcSEcCtD
Cefixime—Gastrointestinal pain—Irinotecan—colon cancer	0.0049	0.0049	CcSEcCtD
Cefixime—Body temperature increased—Vincristine—colon cancer	0.00486	0.00486	CcSEcCtD
Cefixime—Abdominal pain—Vincristine—colon cancer	0.00486	0.00486	CcSEcCtD
Cefixime—Flatulence—Capecitabine—colon cancer	0.00484	0.00484	CcSEcCtD
Cefixime—Abdominal pain—Irinotecan—colon cancer	0.00473	0.00473	CcSEcCtD
Cefixime—Body temperature increased—Irinotecan—colon cancer	0.00473	0.00473	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00464	0.00464	CcSEcCtD
Cefixime—Renal failure—Methotrexate—colon cancer	0.0046	0.0046	CcSEcCtD
Cefixime—Urticaria—Fluorouracil—colon cancer	0.00456	0.00456	CcSEcCtD
Cefixime—Body temperature increased—Fluorouracil—colon cancer	0.00453	0.00453	CcSEcCtD
Cefixime—Hypersensitivity—Vincristine—colon cancer	0.00453	0.00453	CcSEcCtD
Cefixime—Hypersensitivity—Irinotecan—colon cancer	0.00441	0.00441	CcSEcCtD
Cefixime—Leukopenia—Capecitabine—colon cancer	0.00439	0.00439	CcSEcCtD
Cefixime—Agranulocytosis—Methotrexate—colon cancer	0.00436	0.00436	CcSEcCtD
Cefixime—Hypersensitivity—Fluorouracil—colon cancer	0.00422	0.00422	CcSEcCtD
Cefixime—Haemoglobin—Methotrexate—colon cancer	0.00422	0.00422	CcSEcCtD
Cefixime—Diarrhoea—Vincristine—colon cancer	0.00421	0.00421	CcSEcCtD
Cefixime—Haemorrhage—Methotrexate—colon cancer	0.0042	0.0042	CcSEcCtD
Cefixime—Hepatitis—Methotrexate—colon cancer	0.0042	0.0042	CcSEcCtD
Cefixime—Diarrhoea—Irinotecan—colon cancer	0.0041	0.0041	CcSEcCtD
Cefixime—Dizziness—Vincristine—colon cancer	0.00407	0.00407	CcSEcCtD
Cefixime—Pruritus—Fluorouracil—colon cancer	0.00406	0.00406	CcSEcCtD
Cefixime—Erythema multiforme—Methotrexate—colon cancer	0.00397	0.00397	CcSEcCtD
Cefixime—Dizziness—Irinotecan—colon cancer	0.00396	0.00396	CcSEcCtD
Cefixime—Shock—Capecitabine—colon cancer	0.00394	0.00394	CcSEcCtD
Cefixime—Diarrhoea—Fluorouracil—colon cancer	0.00392	0.00392	CcSEcCtD
Cefixime—Thrombocytopenia—Capecitabine—colon cancer	0.00392	0.00392	CcSEcCtD
Cefixime—Vomiting—Vincristine—colon cancer	0.00391	0.00391	CcSEcCtD
Cefixime—Rash—Vincristine—colon cancer	0.00388	0.00388	CcSEcCtD
Cefixime—Dermatitis—Vincristine—colon cancer	0.00387	0.00387	CcSEcCtD
Cefixime—Headache—Vincristine—colon cancer	0.00385	0.00385	CcSEcCtD
Cefixime—Vomiting—Irinotecan—colon cancer	0.00381	0.00381	CcSEcCtD
Cefixime—Dizziness—Fluorouracil—colon cancer	0.00379	0.00379	CcSEcCtD
Cefixime—Rash—Irinotecan—colon cancer	0.00377	0.00377	CcSEcCtD
Cefixime—Dermatitis—Irinotecan—colon cancer	0.00377	0.00377	CcSEcCtD
Cefixime—Headache—Irinotecan—colon cancer	0.00375	0.00375	CcSEcCtD
Cefixime—Nausea—Vincristine—colon cancer	0.00365	0.00365	CcSEcCtD
Cefixime—Vomiting—Fluorouracil—colon cancer	0.00365	0.00365	CcSEcCtD
Cefixime—Rash—Fluorouracil—colon cancer	0.00362	0.00362	CcSEcCtD
Cefixime—Dermatitis—Fluorouracil—colon cancer	0.00361	0.00361	CcSEcCtD
Cefixime—Headache—Fluorouracil—colon cancer	0.00359	0.00359	CcSEcCtD
Cefixime—Nausea—Irinotecan—colon cancer	0.00356	0.00356	CcSEcCtD
Cefixime—Dyspepsia—Capecitabine—colon cancer	0.00353	0.00353	CcSEcCtD
Cefixime—Nausea—Fluorouracil—colon cancer	0.00341	0.00341	CcSEcCtD
Cefixime—Gastrointestinal pain—Capecitabine—colon cancer	0.00328	0.00328	CcSEcCtD
Cefixime—Leukopenia—Methotrexate—colon cancer	0.00327	0.00327	CcSEcCtD
Cefixime—Urticaria—Capecitabine—colon cancer	0.00318	0.00318	CcSEcCtD
Cefixime—Abdominal pain—Capecitabine—colon cancer	0.00317	0.00317	CcSEcCtD
Cefixime—Body temperature increased—Capecitabine—colon cancer	0.00317	0.00317	CcSEcCtD
Cefixime—Convulsion—Methotrexate—colon cancer	0.00317	0.00317	CcSEcCtD
Cefixime—Anaphylactic shock—Methotrexate—colon cancer	0.00298	0.00298	CcSEcCtD
Cefixime—Hypersensitivity—Capecitabine—colon cancer	0.00295	0.00295	CcSEcCtD
Cefixime—Thrombocytopenia—Methotrexate—colon cancer	0.00292	0.00292	CcSEcCtD
Cefixime—Pruritus—Capecitabine—colon cancer	0.00283	0.00283	CcSEcCtD
Cefixime—Diarrhoea—Capecitabine—colon cancer	0.00274	0.00274	CcSEcCtD
Cefixime—Dizziness—Capecitabine—colon cancer	0.00265	0.00265	CcSEcCtD
Cefixime—Dyspepsia—Methotrexate—colon cancer	0.00263	0.00263	CcSEcCtD
Cefixime—Vomiting—Capecitabine—colon cancer	0.00255	0.00255	CcSEcCtD
Cefixime—Rash—Capecitabine—colon cancer	0.00253	0.00253	CcSEcCtD
Cefixime—Dermatitis—Capecitabine—colon cancer	0.00252	0.00252	CcSEcCtD
Cefixime—Headache—Capecitabine—colon cancer	0.00251	0.00251	CcSEcCtD
Cefixime—Gastrointestinal pain—Methotrexate—colon cancer	0.00244	0.00244	CcSEcCtD
Cefixime—Nausea—Capecitabine—colon cancer	0.00238	0.00238	CcSEcCtD
Cefixime—Urticaria—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Cefixime—Abdominal pain—Methotrexate—colon cancer	0.00236	0.00236	CcSEcCtD
Cefixime—Body temperature increased—Methotrexate—colon cancer	0.00236	0.00236	CcSEcCtD
Cefixime—Hypersensitivity—Methotrexate—colon cancer	0.0022	0.0022	CcSEcCtD
Cefixime—Pruritus—Methotrexate—colon cancer	0.00211	0.00211	CcSEcCtD
Cefixime—Diarrhoea—Methotrexate—colon cancer	0.00204	0.00204	CcSEcCtD
Cefixime—Dizziness—Methotrexate—colon cancer	0.00197	0.00197	CcSEcCtD
Cefixime—Vomiting—Methotrexate—colon cancer	0.0019	0.0019	CcSEcCtD
Cefixime—Rash—Methotrexate—colon cancer	0.00188	0.00188	CcSEcCtD
Cefixime—Dermatitis—Methotrexate—colon cancer	0.00188	0.00188	CcSEcCtD
Cefixime—Headache—Methotrexate—colon cancer	0.00187	0.00187	CcSEcCtD
Cefixime—Nausea—Methotrexate—colon cancer	0.00177	0.00177	CcSEcCtD
